Exogenous hormone use and meningioma risk
Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, Wrensch M. Exogenous hormone use and meningioma risk. Cancer 2007, 110: 471-476. PMID: 17580362, DOI: 10.1002/cncr.22783.Peer-Reviewed Original ResearchMeSH KeywordsClinical Trials as TopicContraceptives, Oral, HormonalEstrogen Replacement TherapyHumansMeningeal NeoplasmsMeningiomaRisk FactorsConceptsCase-control studyExogenous hormone useHormone replacement therapyMeningioma riskOral contraceptivesHormone useReplacement therapyHospital-based case-control studyPopulation-based case-control studyRandomized clinical trial dataTumor receptor subtypeRetrospective cohort studyCommon clinical questionsLarge national cohortRisk of meningiomaClinical trial dataEnglish-language literatureCohort studyNational cohortReceptor subtypesClinical questionsIntracranial meningiomasTrial dataFurther evaluationExogenous hormones